Exacte Labs CEO Vasily Kazey published as a coauthor two new scientific articles:
1. A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study. Nikita V. Lomakin, Lyudmila I. Buryachkovskaya, Denis A. Zolin, Vasily I. Kazey
2. First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients. Natalia V. Eremina, Vasily I. Kazey, Sergey V. Mishugin, Roman V. Leonenkov, Dmitry Y. Pushkar4, Vadim L. Mett and Andrei V. Gudkov.
You can find full text articles here.